Skip to main content
TipRanks
Go Ultimate75% OFF

Matthew A. Spear Insider Profile

4 Followers

Matthew A. Spear, former CMO at Poseida Therapeutics, holds 111.48K shares in Poseida Therapeutics (Ticker: PSTX).

Matthew A. Spear's Trading History

PSTX
Poseida Therapeutics
Mar 01, 2022―Uninformative Buy―$1.06M
PSTX

Matthew A. Spear has not reported any informative transactions for PSTX, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 01, 2022Uninformative Buy$0.0050,000$0.00―
Dec 08, 2021Uninformative Buy$13.20K10,000$1.32―
Sep 10, 2021Uninformative Buy$13.20K10,000$1.32―
Aug 24, 2021Uninformative Sell$35.12K4,000$8.78―
Aug 24, 2021Uninformative Buy$5.28K4,000$1.32―

You May Also Like

Matthew A. Spear insider profile FAQ

What stocks does Matthew A. Spear hold?
Matthew A. Spear holds: PSTX stocks.
What is Matthew A. Spear's role in Poseida Therapeutics?
Matthew A. Spear's role in Poseida Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.